FDA publishes list of surrogate endpoints for clin

FDA publishes list of surrogate endpoints for clinical trials, scientists are not happy with the sloppiness of the list. The last paragraph of this article has a good definition -- here's FDA's definition --

Quote:

---

term ‘surrogate endpoint’ means a marker, such as a laboratory measurement, radiographic image, physical sign, or other measure, that is not itself a direct measurement of clinical benefit, and (A) is known to predict clinical benefit and could be used to support traditional approval of a drug or biological product; or (B ) is reasonably likely to predict clinical benefit and could be used to support the accelerated approval of a drug or biological product in accordance with section 506(c).”

---

https://endpts.com/fda-outlines-a-laundry-lis...developers